EASL Guidelines vs ESOT Congress

The EASL Guidelines app is designed to assist healthcare professionals and allied healthcare professionals in their daily clinic decision making. Discover the EASL Clinical Practice Guidelines (CPGs) in a mobile-friendly format to get the best recommendations for patient management. The app includes the most up to date EASL CPGs and Policy Statements, covering all areas of hepatology, together with the following key features: Guidelines recommendations and full text version (in PDF) Bookmark and note function Keyword search Discovery tab linking to additional EASL contents of interest Offline mode ensuring permanent access to the content wherever you are located Download the app now and get your guidelines assistant always with you! Disclaimer The EASL Guidelines app is designed for professional use delivering instant medical information and clinical recommendations to medical experts (i.e. hepatologists, gastroenterologists and internal medicine specialists) that may aid them in delivering patient care. Patients and other members of the community who use this app should only do so after consulting with a healthcare professional, and they should not consider these guidelines as a substitute for professional medical advice. Guidelines and recommendations included in this app may not be universally applicable and should be understood within the context of particular clinical scenarios and resource constraints. It is the responsibility of each health care professional to tailor these guidelines according to local regulations and the unique circumstances and requirements of each patient.

Nurturing a sustainable transplantation journey The ESOT Congress is the leading forum for inspiration in transplantation. Offering endless possibilities on a global scale, the meeting is a platform for growth and collaboration like no other. Through state-of-the-art science and cutting-edge innovation, attendees will unlock a wealth of new knowledge, uncovering answers to their burning clinical questions in 2025 and beyond.